102 related articles for article (PubMed ID: 15856462)
1. Immune responses to DNA mismatch repair enzymes hMSH2 and hPMS1 in patients with pancreatic cancer, dermatomyositis and polymyositis.
Okada T; Noji S; Goto Y; Iwata T; Fujita T; Okada T; Matsuzaki Y; Kuwana M; Hirakata M; Horii A; Matsuno S; Sunamura M; Kawakami Y
Int J Cancer; 2005 Oct; 116(6):925-33. PubMed ID: 15856462
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of human mismatch repair genes in adult T-cell leukemia.
Morimoto H; Tsukada J; Kominato Y; Tanaka Y
Am J Hematol; 2005 Feb; 78(2):100-7. PubMed ID: 15682421
[TBL] [Abstract][Full Text] [Related]
3. Expression of the DNA mismatch repair proteins (hMLH1 and hMSH2) in infiltrating pancreatic cancer and its relation to some phenotypic features.
Tomaszewska R; Okoń K; Stachura J
Pol J Pathol; 2003; 54(1):31-7. PubMed ID: 12817878
[TBL] [Abstract][Full Text] [Related]
4. Correlation between patterns of DNA mismatch repair hmlh1 and hmsh2 protein expression and progression of dysplasia in intraductal papillary mucinous neoplasms of the pancreas.
Handra-Luca A; Couvelard A; Degott C; Fléjou JF
Virchows Arch; 2004 Mar; 444(3):235-8. PubMed ID: 14760534
[TBL] [Abstract][Full Text] [Related]
5. Defective DNA mismatch repair in long-term (> or =3 years) survivors with pancreatic cancer.
Maple JT; Smyrk TC; Boardman LA; Johnson RA; Thibodeau SN; Chari ST
Pancreatology; 2005; 5(2-3):220-7; discussion 227-8. PubMed ID: 15855819
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic mucinous noncystic (colloid) carcinomas and intraductal papillary mucinous carcinomas are usually microsatellite stable.
Lüttges J; Beyser K; Pust S; Paulus A; Rüschoff J; Klöppel G
Mod Pathol; 2003 Jun; 16(6):537-42. PubMed ID: 12808058
[TBL] [Abstract][Full Text] [Related]
7. DNA mismatch repair enzyme activity and gene expression in prostate cancer.
Yeh CC; Lee C; Dahiya R
Biochem Biophys Res Commun; 2001 Jul; 285(2):409-13. PubMed ID: 11444857
[TBL] [Abstract][Full Text] [Related]
8. Mismatch repair protein hMSH2 in primary drug resistance in in vitro human malignant gliomas.
Rellecke P; Kuchelmeister K; Schachenmayr W; Schlegel J
J Neurosurg; 2004 Oct; 101(4):653-8. PubMed ID: 15481721
[TBL] [Abstract][Full Text] [Related]
9. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
[TBL] [Abstract][Full Text] [Related]
10. Expression of the mismatch repair protein hMSH2 in carcinoma in situ and invasive cancer of the breast.
Bock N; Meden H; Regenbrecht M; Jünemann B; Wangerin J; Marx D
Anticancer Res; 2000; 20(1A):119-24. PubMed ID: 10769643
[TBL] [Abstract][Full Text] [Related]
11. Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells.
Balogh GA; Russo IH; Russo J
Int J Oncol; 2003 Aug; 23(2):411-9. PubMed ID: 12851690
[TBL] [Abstract][Full Text] [Related]
12. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.
Shin KH; Shin JH; Kim JH; Park JG
Cancer Res; 2002 Jan; 62(1):38-42. PubMed ID: 11782355
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of transforming growth factor beta receptor type II and DNA mismatch repair genes in sporadic endometrial carcinomas with microsatellite instability.
Ohwada M; Suzuki M; Saga Y; Suzuki T; Ikeda M; Yamada M; Sato I
Oncol Rep; 2000; 7(4):789-92. PubMed ID: 10854545
[TBL] [Abstract][Full Text] [Related]
15. Very low incidence of microsatellite instability in intraductal papillary-mucinous neoplasm of the pancreas.
Nakata B; Yashiro M; Nishioka N; Aya M; Yamada S; Takenaka C; Ohira M; Ishikawa T; Nishino H; Wakasa K; Seki S; Hirakawa K
Int J Cancer; 2002 Dec; 102(6):655-9. PubMed ID: 12448010
[TBL] [Abstract][Full Text] [Related]
16. The mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP.
Leach FS; Velasco A; Hsieh JT; Sagalowsky AI; McConnell JD
J Urol; 2000 Nov; 164(5):1830-3. PubMed ID: 11025778
[TBL] [Abstract][Full Text] [Related]
17. Detection of an involvement of the human mismatch repair genes hMLH1 and hMSH2 in nucleotide excision repair is dependent on UVC fluence to cells.
Lee DF; Drouin R; Pitsikas P; Rainbow AJ
Cancer Res; 2004 Jun; 64(11):3865-70. PubMed ID: 15172995
[TBL] [Abstract][Full Text] [Related]
18. Various mutation screening techniques in the DNA mismatch repair genes hMSH2 and hMLH1.
Wahlberg S; Liu T; Lindblom P; Lindblom A
Genet Test; 1999; 3(3):259-64. PubMed ID: 10495924
[TBL] [Abstract][Full Text] [Related]
19. [Effect of eukaryotic expression plasmid DNA methyltransferase gene on methylation status and transcription level of DNA mismatch repair genes in human colon cancer cell line].
Lu R; Fang JY; Zhu HY; Chen YX; Cheng ZH; Li EL
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):1014-7. PubMed ID: 15312538
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]